Merck & Co Inc (MRK)
99.18
-0.68
(-0.68%)
USD |
NYSE |
Nov 22, 16:00
99.31
+0.13
(+0.13%)
After-Hours: 20:00
Merck Cash and Short Term Investments (Quarterly): 14.59B for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.59B |
| June 30, 2024 | 11.35B |
| March 31, 2024 | 5.619B |
| December 31, 2023 | 7.093B |
| September 30, 2023 | 8.773B |
| June 30, 2023 | 6.378B |
| March 31, 2023 | 10.39B |
| December 31, 2022 | 13.19B |
| September 30, 2022 | 11.25B |
| June 30, 2022 | 10.13B |
| March 31, 2022 | 8.928B |
| December 31, 2021 | 8.096B |
| September 30, 2021 | 10.02B |
| June 30, 2021 | 8.575B |
| March 31, 2021 | 6.981B |
| December 31, 2020 | 8.05B |
| September 30, 2020 | 7.356B |
| June 30, 2020 | 11.10B |
| March 31, 2020 | 7.432B |
| December 31, 2019 | 10.45B |
| September 30, 2019 | 8.018B |
| June 30, 2019 | 7.105B |
| March 31, 2019 | 8.798B |
| December 31, 2018 | 8.864B |
| September 30, 2018 | 10.28B |
| Date | Value |
|---|---|
| June 30, 2018 | 7.594B |
| March 31, 2018 | 7.346B |
| December 31, 2017 | 8.498B |
| September 30, 2017 | 11.20B |
| June 30, 2017 | 11.97B |
| March 31, 2017 | 15.25B |
| December 31, 2016 | 14.34B |
| September 30, 2016 | 13.07B |
| June 30, 2016 | 11.83B |
| March 31, 2016 | 12.94B |
| December 31, 2015 | 13.43B |
| September 30, 2015 | 12.09B |
| June 30, 2015 | 11.37B |
| March 31, 2015 | 15.60B |
| December 31, 2014 | 15.72B |
| September 30, 2014 | 14.35B |
| June 30, 2014 | 13.40B |
| March 31, 2014 | 20.51B |
| December 31, 2013 | 17.49B |
| September 30, 2013 | 18.17B |
| June 30, 2013 | 18.10B |
| March 31, 2013 | 16.02B |
| December 31, 2012 | 16.14B |
| September 30, 2012 | 18.12B |
| June 30, 2012 | 17.45B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.619B
Minimum
Mar 2024
14.59B
Maximum
Sep 2024
9.288B
Average
8.850B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amgen Inc | 9.011B |
| Johnson & Johnson | 20.30B |
| Eli Lilly and Co | 3.518B |
| Pfizer Inc | 9.952B |
| Moderna Inc | 6.867B |